Advertisement

Obg Management Logo Home
   
   
Free CME
Classifieds
Register/Login
Home Page Current Issue Past Issues Supplements Podcasts Information for Authors
                                    
   
About Us
Subscribe Renew
Reprints Permissions
Advertising Information
Links and Resources
Classifieds

Advertisement

October 2003 · Vol. 15, No. 10

Metformin for PCOS symptoms: 5 challenging cases

This inexpensive and versatile drug broadens the choices for treating polycystic ovary syndrome. An expert describes its efficacy for common manifestations of PCOS.


ROBERT  L.  BARBIERI,  MD

EDITOR-IN-CHIEF

Dr. Barbieri is chief of the department of obstetrics and gynecology at Brigham and Women’s Hospital in Boston, Mass, and Kate Macy Ladd Professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School. He is editor-in-chief of OBG Management.

KEY POINTS

  • Metformin’s role in treatment of PCOS varies with the patient’s chief complaint, clinical characteristics, and lifestyle.

  • The primary uses of metformin in treating PCOS are to induce ovulation in women resistant to clomiphene alone and to treat oligomenorrhea in women who can’t or won’t use oral contraceptives.

  • To be a candidate for metformin treatment, a patient must have a serum creatinine lower than 1.4 mg/dL to avoid the risk of developing lactic acidosis.

Inducing ovulation. Decreasing insulin resistance. Facilitating weight loss. These are a few of the benefits metformin offers women with polycystic ovary syndrome (PCOS). This article’s 5 case histories illustrate a range of major complaints and secondary factors to consider in making prescribing decisions.

The decision to use metformin depends on the patient’s major PCOS-related complaint (TABLE 1), as well as other considerations. In some cases, metformin may not be appropriate at all.

Sign in now to read more...

Back to top


Advertisement



ADVERTISEMENT   

ADVERTISEMENT   
ADVERTISEMENT   
Subscribe to our e-mail alert. We'll notify you of upcoming articles every month—and send you links to them before they are published.

Changing your e-mail address?
 
INSTANT POLL
What nonhormonal menopause interventions have you found to be effective?

ADVERTISEMENT